|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China, 2013. Cancer Lett. 401:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turner RM II, Morgan TM and Jacobs BL:
Epidemiology of the Small Renal Mass and the treatment disconnect
phenomenon. Urol Clin North Am. 44:147–154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perry SV: Vertebrate tropomyosin:
Distribution, properties and function. J Muscle Res Cell Motil.
22:5–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Helfman DM, Flynn P, Khan P and Saeed A:
Tropomyosin as a regulator of cancer cell transformation. Adv Exp
Med Biol. 644:124–131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bharadwaj S and Prasad GL: Tropomyosin-1,
a novel suppressor of cellular transformation is down regulated by
promoter methylation in cancer cells. Cancer Lett. 183:205–213.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petrova DT, Asif AR, Armstrong VW, Dimova
I, Toshev S, Yaramov N, Oellerich M and Toncheva D: Expression of
chloride intracellular channel protein 1 (CLIC1) and tumor protein
D52 (TPD52) as potential biomarkers for colorectal cancer. Clin
Biochem. 41:1224–1236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ku BM, Ryu HW, Lee YK, Ryu J, Jeong JY,
Choi J, Cho HJ, Park KH and Kang SS:
4′-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits
glioma growth and invasion through regulation of the tropomyosin 1
gene. Biochem Biophys Res Commun. 402:525–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yager ML, Hughes JA, Lovicu FJ, Gunning
PW, Weinberger RP and O'Neill GM: Functional analysis of the
actin-binding protein, tropomyosin 1, in neuroblastoma. Br J
Cancer. 89:860–863. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Guan J, Lu Z, Jin J, Cai Y, Wang C
and Wang F: Clinical and tumor significance of tropomyosin-1
expression levels in renal cell carcinoma. Oncol Rep. 33:1326–1334.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan H, Gu L, Liu B, Li Y, Wang Y, Bai X,
Li L, Wang B, Peng Q, Yao Z and Tang Z: Tropomyosin-1 acts as a
potential tumor suppressor in human oral squamous cell carcinoma.
PLoS One. 12:e01689002017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang W, Wang X, Zheng W, Li K, Liu H and
Sun Y: Genetic and epigenetic alterations are involved in the
regulation of TPM1 in cholangiocarcinoma. Int J Oncol. 42:690–698.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
England J, Granados-Riveron J, Polo-Parada
L, Kuriakose D, Moore C, Brook JD, Rutland CS, Setchfield K, Gell
C, Ghosh TK, et al: Tropomyosin 1: Multiple roles in the developing
heart and in the formation of congenital heart defects. J Mol Cell
Cardiol. 106:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lv L, Huang F, Mao H, Li M, Li X, Yang M
and Yu X: MicroRNA-21 is overexpressed in renal cell carcinoma. Int
J Biol Markers. 28:201–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao
H, Sun Q, Yan F, Yan C, Li H and Ren X: Diagnostic and prognostic
value of circulating miR-21 for cancer: A systematic review and
meta-analysis. Gene. 533:389–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sekar D, Krishnan R, Thirugnanasambantham
K, Rajasekaran B, Islam VI and Sekar P: Significance of microRNA 21
in gastric cancer. Clin Res Hepatol Gastroenterol. 40:538–545.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin ZY and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Breckenridge DG, Germain M, Mathai JP,
Nguyen M and Shore GC: Regulation of apoptosis by endoplasmic
reticulum pathways. Oncogene. 22:8608–8618. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Newmeyer DD and Ferguson-Miller S:
Mitochondria: Releasing power for life and unleashing the
machineries of death. Cell. 112:481–490. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pradelli LA, Bénéteau M and Ricci JE:
Mitochondrial control of caspase-dependent and -independent cell
death. Cell Mol Life Sci. 67:1589–1597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tait SW and Green DR: Mitochondrial
regulation of cell death. Cold Spring Harb Perspect Biol.
5:pii:a0087062013. View Article : Google Scholar
|
|
24
|
Ashkenazi A and Dixit VM: Death receptors:
Signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dashzeveg N and Yoshida K: Cell death
decision by p53 via control of the mitochondrial membrane. Cancer
Lett. 367:108–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Glab JA, Doerflinger M, Nedeva C, Jose I,
Mbogo GW, Paton JC, Paton AW, Kueh AJ, Herold MJ, Huang DC, et al:
DR5 and caspase-8 are dispensable in ER stress-induced apoptosis.
Cell Death Differ. 24:944–950. 2017. View Article : Google Scholar : PubMed/NCBI
|
